Global lessons from Nigerias ebolavirus control strategy

Expert Review of Vaccines

Volumn 14, Issue 11, 2015, Pages 1397-1400

  Elemuwa, Chris ^a   Kutalek, Ruth ^b   Ali, Mohammad ^c   Mworozi, Edison ^d   Kochhar, Sonali ^e   Rath, Barbara ^f   Safety Initiative, Vienna Vaccine ^g  

^a National Primary Healthcare Development Agency (NPHCDA)   (Nigeria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^e Department of Maternal   (India)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g NONE   (Germany)

Author keywords

ebola viruss; ebolavirus disease; infrastructure; Nigeria; outbreak; polio surveillance; vaccines

Indexed keywords

EBOLA VACCINE;

CONTROL STRATEGY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HUMAN; INFECTION CONTROL; NIGERIA; NONHUMAN; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; VACCINATION; COMMUNICABLE DISEASE CONTROL; DISEASE TRANSMISSION; EPIDEMIOLOGICAL MONITORING; HEMORRHAGIC FEVER, EBOLA; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; PREVENTION AND CONTROL; PROCEDURES; TRANSMISSION;

COMMUNICABLE DISEASE CONTROL; DISEASE TRANSMISSION, INFECTIOUS; EPIDEMIOLOGICAL MONITORING; HEMORRHAGIC FEVER, EBOLA; HUMANS; INTERNATIONAL COOPERATION; NIGERIA; PUBLIC-PRIVATE SECTOR PARTNERSHIPS;

EID: 84944904185     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2015.1064313     Document Type: Review

References (13)

1. Baize S. Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus. Curr Opin Virol 2015; 10: 70-6
2. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014; 371 (22): 2092-100
3. Igonoh AK. My experience as an Ebola patient. Am J Trop Med Hyg 2015; 92 (2): 221-2
4. Kutalek R, Wang S, Fallah M, et al. Ebola interventions: listen to communities. Lancet Glob Health 2015; 3 (3): e131
5. Pandey A, Atkins KE, Medlock J, et al. Strategies for containing Ebola in West Africa. Science 2014; 346 (6212): 991-5
6. CDC. Update: Ebola virus disease epidemic-West Africa, November 2014. MMWR Morb Mortal Wkly Rep 2014; 63 (46): 1064-6
7. Rath B, Ali M, Elemuwa C, et al. Prioritizing polio. Expert Rev Vaccines 2012; 11 (12): 1389-92
8. Mbonye AK, Wamala JF, Nanyunja M, et al. Ebola viral hemorrhagic disease outbreak in West Africa-lessons from Uganda. Afr Health Sci 2014; 14 (3): 495-501
9. Abramowitz SA, Bardosh KL, Leach M, et al. Social science intelligence in the global Ebola response. The Lancet 2015; 385 (9965): 330
10. Carter M. How Twitter may have helped Nigeria contain Ebola. BMJ 2014; 349: g6946
11. Kochhar S, Rath B, Seeber LD, et al. Introducing new vaccines in developing countries. Expert Rev Vaccines 2013; 12 (12): 1465-78
12. WHO. WHO Ebola R&D Effort-vaccines, therapies, diagnostics. 2015. Available from: www.who.int/medicines/ebola-treatment/ebola-r-d-effort/en/. [Last accessed 2 February 2015]
13. WHO. Ebola vaccines, therapies, and diagnostics: Questions and Answers. 2015. Available from: www.who.int/medicines/emp-ebola-q-as/en/. [Last accessed 2 February 2015]